AMT-116 Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 1/2: 2

Top Sponsors

Multitude Therapeutics Inc.3

Indications

Cancer3
Advanced Non Small Cell Lung Cancer (NSCLC)1
Advanced Solid Tumors1
Advanced Solid Tumor1
Lung Cancer1

Other2 trials

AMT-116 in Combination With Ivosidan in Patients With Lung Cancer

Phase 1/2

AMT-116 in Patients with Solid Tumors

Phase 1/2

Denver, Colorado1 trial

AMT-116 in Patients With Advanced Solid Tumors

Sarah Cannon Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.